ESTRO Guide 2018

First page Table of contents Previous page 132 Next page Last page

TEACHING LECTURE

A primer on value based health care

The systematic use of patient reported outcome measures (PROM) for the improvement of radiotherapy

DNA Repair: from mechanisms to clinical implication

Is stereotactic body radiotherapy an alternative to surgery in operable patients with stage I NSCLC?

08:00 - 08:40

SYMPOSIUM

Value-based radiation oncology Defining international standardisation of value in health care - Implementing value-based health care at Karolinska University Hospital, Stockholm - Introducing the value-equation in oncology, specific focus on radiation oncology - Towards value based radiation oncology in European oncology

Radiomics – Technical and clinical challenges and opportunities Radiomics: what about harmonisation and standardisation? - Radiomics – Clinical challenges and opportunities – Will radiomics change our practice in the next years? - Radiomics – How does artificial intelligence shape the future of medical imaging?

Genomic instability and DNA repair in cancer DNA damage responses as a barrier against carcinogenesis - Replication stress as a driver of genomic instability in malignant gliomas - The translational impact of targeting DNA repair

Evolving role of radiotherapy in the management of SCLC Towards individualised dose-constraints for dose- limiting toxicity - Functional-imaging guided dose-escalation - New trends in the management of SCLC - How to manage SCLC cancer patients with brain metastasis?

08:45 - 10:00

MONDAY 23 APRIL 2018

10:00 - 10:30

COFFEE BREAK

SYMPOSIUM

PROFFERED PAPERS

Enhancing radiation oncology outcomes through patient involvement Patient reported outcome measures as an endpoint in clinical trials - The impact of patient values on treatment techniques and decisions in radiation oncology - Supporting patients through communication to take an active role in shared decision making

Radiogenomics Knowing the landscape to be explored - GWAS in radiogenomics -

10:30 - 11:45

The REQUITE project: integrating biomarkers and clinical predictors of radiotherapy side effects - Machine learning algorithms in the analysis of complex SNP data

12:00 - 12:30

SELECTED RANDOMISED TRIALS

12:30 - 13:00

KLAAS BREUR AWARD LECTURE

13:00 - 14:30

LUNCH AND INDUSTRY SYMPOSIA

SYMPOSIUM

JOINT SYMPOSIUM

SYMPOSIUM

DEBATE

ESTRO-ESR New imaging approaches for radiotherapy

Challenges in human resources in radiotherapy Human resources in radiation oncology: how to predict changing needs in a changing world? - Tradition and innovation: reshaping the professional and scientific role of medical physicists in radiotherapy - Radiation Therapist: what’s in a word? - Innovative education to cover the gaps

Biomarker driven hypoxic modification Genomic biomarkers for selection of patients to hypoxia modification - Multi-parametric functional imaging for patient stratification and hypoxia modification - Clinical trials

This house believes that treatment intensification in stage III is a dream rather than a reality

14:30 - 15:45

15:45 - 16:15

COFFEE BREAK

SYMPOSIUM

PROFFERED PAPERS

Planning future global radiotherapy services

Normal tissue dose-response modelling across radiation modalities Comparison and limitations of DVH-based NTCP models derived from 3D-CRT and IMRT data - Clinical evidence of spatially variable proton biologi- cal effectiveness in pediatric brain tumour patients - Patient-reported outcomes and associated dose response models for prostate cancer patients treated with photon vs. proton therapy - Validation of photon-derived normal tissue complication probability models in a head and neck proton therapy cohort

16:15 - 17:30

CONFERENCES

17:40 - 18:00

JENS OVERGAARD LEGACY AWARD

18:00 - 18:10

ACADEMIC AWARD LECTURE: JACK FOWLER UNIVERSITY OF WISCONSIN AWARD

18:10 - 18:30

COMPANY AWARD LECTURES

132

Made with FlippingBook Online newsletter